J Prignot

1.2k total citations
53 papers, 966 citations indexed

About

J Prignot is a scholar working on Infectious Diseases, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Prignot has authored 53 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Physiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Prignot's work include Tuberculosis Research and Epidemiology (14 papers), Smoking Behavior and Cessation (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). J Prignot is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Smoking Behavior and Cessation (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). J Prignot collaborates with scholars based in Belgium, United States and Democratic Republic of the Congo. J Prignot's co-authors include Pierre Masson, J.F. Heremans, G Wauters, Joseph H. Perriëns, Robert W. Ryder, Prakash C. Gupta, Robert Colebunders, Peter Piot, Tjandra Yoga Aditama and C. Cocito and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

J Prignot

48 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Prignot Belgium 15 342 307 218 178 175 53 966
Robert Rothbaum United States 17 278 0.8× 347 1.1× 78 0.4× 68 0.4× 264 1.5× 28 1.4k
Sunil Gomber India 18 203 0.6× 168 0.5× 90 0.4× 140 0.8× 118 0.7× 87 1.1k
F. Rosmini Italy 13 248 0.7× 191 0.6× 328 1.5× 82 0.5× 58 0.3× 29 974
Kazuo Shiraki Japan 20 242 0.7× 492 1.6× 34 0.2× 298 1.7× 410 2.3× 60 1.5k
K M Citron United Kingdom 22 681 2.0× 537 1.7× 289 1.3× 685 3.8× 365 2.1× 59 1.7k
Marion Aw Singapore 20 149 0.4× 386 1.3× 133 0.6× 63 0.4× 475 2.7× 110 1.6k
P. Raghupathy India 19 145 0.4× 233 0.8× 71 0.3× 38 0.2× 149 0.9× 65 1.1k
Tiziana Quirino Italy 22 841 2.5× 331 1.1× 177 0.8× 41 0.2× 82 0.5× 60 1.5k
James G. Dinulos United States 17 115 0.3× 235 0.8× 69 0.3× 110 0.6× 87 0.5× 52 1.1k
William R. Crombleholme United States 22 76 0.2× 442 1.4× 127 0.6× 104 0.6× 185 1.1× 45 1.9k

Countries citing papers authored by J Prignot

Since Specialization
Citations

This map shows the geographic impact of J Prignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Prignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Prignot more than expected).

Fields of papers citing papers by J Prignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Prignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Prignot. The network helps show where J Prignot may publish in the future.

Co-authorship network of co-authors of J Prignot

This figure shows the co-authorship network connecting the top 25 collaborators of J Prignot. A scholar is included among the top collaborators of J Prignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Prignot. J Prignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Annemans, Lieven, et al.. (2009). Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation. Clinical Drug Investigation. 29(10). 655–665. 39 indexed citations
2.
Prignot, J, et al.. (2008). Alternative forms of tobacco use.. PubMed. 12(7). 718–27. 60 indexed citations
3.
Prignot, J & Jacques Jamart. (2005). What can be learnt from tobacco butts? An observational study in a realistic hospital setting.. PubMed. 9(2). 210–5. 7 indexed citations
4.
Prignot, J, Peter Bärtsch, P. Vermeire, et al.. (2000). Physicians’ Involvement in the Smoking Cessation Process of their Patients. Acta Clinica Belgica. 55(5). 266–275. 9 indexed citations
5.
Perriëns, Joseph H., et al.. (1994). Anti-A60 immunoglobulin G in the serodiagnosis of tuberculosis in HIV-seropositive and seronegative patients. AIDS. 8(9). 1277–1280. 8 indexed citations
6.
Zou, Yong, et al.. (1994). Serological Analysis of Pulmonary and Extrapulmonary Tuberculosis with Enzyme-Linked Immunosorbent Assays for Anti-A60 Immunoglobulins. Clinical Infectious Diseases. 19(6). 1084–1091. 23 indexed citations
7.
Klausner, Jeffrey D., et al.. (1993). Mycobacterium tuberculosis in Household Contacts of Human Immunodeficiency Virus Type 1-Seropositive Patients with Active Pulmonary Tuberculosis in Kinshasa, Zaire. The Journal of Infectious Diseases. 168(1). 106–111. 34 indexed citations
8.
Mukadi, Ya Diul, Jos Perriëns, Michael E. St. Louis, et al.. (1993). Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. The Lancet. 342(8864). 143–146. 99 indexed citations
9.
10.
Prignot, J, et al.. (1990). Serological Analysis of Human Tuberculosis by an ELISA with Mycobacterial Antigen 60. Scandinavian Journal of Infectious Diseases. 22(1). 63–73. 35 indexed citations
11.
Humblet, Yves, P. Weynants, André Bosly, et al.. (1989). Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: A dose escalation study of carboplatin. Medical Oncology and Tumor Pharmacotherapy. 6(3). 207–212. 14 indexed citations
12.
Collard, Philippe, et al.. (1989). Improvement of oxygen delivery in severe hypoxaemia by a reservoir cannula. European Respiratory Journal. 2(8). 778–781. 10 indexed citations
13.
Prignot, J. (1988). Home monitoring of patients on long-term oxygen therapy.. PubMed. 62(1-2). 33–4. 2 indexed citations
14.
Canon, Jean-Luc, Yves Humblet, Anne‐Marie Lebacq‐Verheyden, et al.. (1988). Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. European Journal of Cancer and Clinical Oncology. 24(2). 147–150. 20 indexed citations
15.
Delaunois, Luc, Elliott Salamon, & J Prignot. (1985). Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.. PubMed. 55(2). 150–2. 3 indexed citations
16.
Symann, Michel, Yves Humblet, André Bosly, Julie‐Ann Francis, & J Prignot. (1984). Late Intensification for Small Cell Lung-cancer - a Randomized Trial. Experimental Hematology. 12(6). 387–387. 1 indexed citations
17.
Prignot, J, André Bosly, Michel Symann, et al.. (1982). Late Intensification Chemotherapy and Autologous Bone-marrow Transplantation in Small Cell Lung-cancer. DIAL (Catholic University of Leuven). 63. 43–43. 1 indexed citations
18.
Prignot, J, et al.. (1980). Evaluation of onset of bronchodilating effect by interruption of the air flow method.. PubMed. 61(2). 108–12. 4 indexed citations
19.
Prignot, J. (1978). [Phlebography as diagnostic aid in pulmonary thrombo-embolism (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 69(1). 3–15. 1 indexed citations
20.
Francis, Charles K., Christine Bonnet, & J Prignot. (1978). La biopsie pulmonaire par voie endobronchique. Acta Endoscopica. 8(4). 261–271.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Rothbaum Breakdown of academic impact, for papers by Sunil Gomber Breakdown of academic impact, for papers by F. Rosmini Breakdown of academic impact, for papers by Kazuo Shiraki Breakdown of academic impact, for papers by K M Citron Breakdown of academic impact, for papers by Marion Aw Breakdown of academic impact, for papers by P. Raghupathy Breakdown of academic impact, for papers by Tiziana Quirino Breakdown of academic impact, for papers by James G. Dinulos Breakdown of academic impact, for papers by William R. Crombleholme
Rankless by CCL
2026